Clinical Trial Update: A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating Stellate Ganglion Block to prevent atrial fibrillation, currently recruiting for Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 2, Phase 3 | Status: RECRUITING